Cystic Fibrosis: 'Life-changing' drugs approved in NI

A deal has been reached to allow patients in Northern Ireland access to drugs that treat the life-limiting condition cystic fibrosis .

Kaftrio, Symkevi and Orkambi are modular drugs that work to treat the root cause by bypassing the genetic errors responsible for the disease. The company said it has finalised a reimbursement agreement to allow for "extended long-term access" to the medication for all eligible existing and future patients."The newly published final draft Nice guidance will underpin continued access to these life-changing treatments for new and existing patients in Northern Ireland, where treatment is considered clinically appropriate by their treating clinician," he said.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lung-targeting lipid nanoparticles with CRISPR components successfully treat cystic fibrosis mouse modelsA team of medical researchers from the University of Texas Southwestern Medical Center, Case Western Reserve University School of Medicine and ReCode Therapeutics has developed a way to send gene-editing tools to the lungs to repair the faulty gene associated with cystic fibrosis.
Source: physorg_com - 🏆 388. / 55 Read more »